Skip to content
10-Q

Quarterly Report

Zevra Therapeutics, Inc. ZVRA

0001628280-25-039967

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 56.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 56.32M sh
Shares Diluted Q2 2025 · Jun 30, 2025 56.06M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.9M sh
Shares Diluted Q2 2025 · Jun 30, 2024 41.84M sh
Capex Q2 2025 · Jun 30, 2025 $312K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$11.82M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$35.27M
Long Term Debt Q2 2025 · Jun 30, 2025 $60.69M
Long Term Debt Q2 2025 · Dec 31, 2024 $59.5M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $47.71M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $33.79M
Stockholders Equity Q2 2025 · Jun 30, 2025 $117.23M
Stockholders Equity Q2 2025 · Mar 31, 2025 $41.02M
Stockholders Equity Q2 2025 · Dec 31, 2024 $39.67M
Stockholders Equity Q2 2025 · Jun 30, 2024 $32.48M
Stockholders Equity Q2 2025 · Mar 31, 2024 $48.82M
Stockholders Equity Q2 2025 · Dec 31, 2023 $61.86M
Current Liabilities Q2 2025 · Jun 30, 2025 $28.83M
Current Liabilities Q2 2025 · Dec 31, 2024 $34.07M
Total Liabilities Q2 2025 · Jun 30, 2025 $139.05M
Total Liabilities Q2 2025 · Dec 31, 2024 $138.46M
Current Assets Q2 2025 · Jun 30, 2025 $226.34M
Current Assets Q2 2025 · Dec 31, 2024 $86.03M
Total Assets Q2 2025 · Jun 30, 2025 $256.28M
Total Assets Q2 2025 · Dec 31, 2024 $178.13M
Eps Diluted Q2 2025 · Jun 30, 2025 $1.21
Eps Diluted Q2 2025 · Jun 30, 2025 $1.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.48
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.87
Eps Basic Q2 2025 · Jun 30, 2025 $1.24
Eps Basic Q2 2025 · Jun 30, 2025 $1.20
Eps Basic Q2 2025 · Jun 30, 2024 −$0.48
Eps Basic Q2 2025 · Jun 30, 2024 −$0.87
Sga Expense Q2 2025 · Jun 30, 2025 $20.78M
Sga Expense Q2 2025 · Jun 30, 2025 $40.33M
Sga Expense Q2 2025 · Jun 30, 2024 $12.6M
Sga Expense Q2 2025 · Jun 30, 2024 $22.54M
Net Income Q2 2025 · Jun 30, 2025 $74.71M
Net Income Q2 2025 · Jun 30, 2025 $71.61M
Net Income Q2 2025 · Mar 31, 2025 −$3.1M
Net Income Q2 2025 · Jun 30, 2024 −$19.93M
Net Income Q2 2025 · Jun 30, 2024 −$36.55M
Net Income Q2 2025 · Mar 31, 2024 −$16.62M
Operating Income Q2 2025 · Jun 30, 2025 −$71.04M
Operating Income Q2 2025 · Jun 30, 2025 −$76.4M
Operating Income Q2 2025 · Jun 30, 2024 −$23.8M
Operating Income Q2 2025 · Jun 30, 2024 −$44.28M